| Ms Susan Ann Giblin, MA, LMHC | |
|
45 Waterman Ave, Cranston, RI 02910-4519 | |
| (401) 623-9265 | |
| Not Available |
| Full Name | Ms Susan Ann Giblin |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 45 Waterman Ave, Cranston, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740401975 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | MHC00121 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Susan Ann Giblin, MA, LMHC 45 Waterman Ave, Cranston, RI 02910-4519 Ph: (401) 623-9265 | Ms Susan Ann Giblin, MA, LMHC 45 Waterman Ave, Cranston, RI 02910-4519 Ph: (401) 623-9265 |
News Archive
December has been a busy month for the European Commission, and Despina Spanou, Principal Adviser at the Directorate General for Health and Consumers, talks to EUFIC, about Europe's Nutrition Strategy mid-term progress report, the evaluation of the EU Platform for Action on Diet, Physical Activity and Health, the OECD/EC report "Health at a Glance: Europe 2010", and the Belgian Presidency/EC Conference on Monitoring and Evaluation of EU and Member States' strategies on nutrition, overweight and obesity-related health issues.
Acute T-cell lymphoblastic leukemia is a rare type of blood cancer that affects mostly children. This blood cancer appears from the precursor cells that produce T lymphocytes.
The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can't be removed by surgery, and that has a certain type of abnormal gene (BRAF V600E or V600K mutation).
Disruption of a single gene, Nrf2, plays a critical role in regulating the body's innate immune response to sepsis and septic shock, according to a study by a research team led by Shyam Biswal, PhD, at the Johns Hopkins Bloomberg School of Public Health.
Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company has completed patient enrollment of its Phase 2 study with an experimental oral parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.
› Verified 8 days ago
Arturo Ramirez, Counselor Medicare: Not Enrolled in Medicare Practice Location: 9 Carlo Ct, Cranston, RI 02921 Phone: 781-697-9225 | |
Kathy Young, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1471 Elmwood Ave, Cranston, RI 02910 Phone: 401-724-8400 Fax: 401-722-5280 | |
Jaimie Gutierrez, LMHC-A Counselor Medicare: Not Enrolled in Medicare Practice Location: 1052 Park Ave, Cranston, RI 02910 Phone: 401-461-5056 | |
Elisabeth Merrell, Counselor Medicare: Not Enrolled in Medicare Practice Location: 15 Fleming Rd, Cranston, RI 02920 Phone: 800-455-8839 Fax: 866-455-8839 | |
Jeremy May, MASTERS, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1471 Elmwood Ave, Cranston, RI 02910 Phone: 401-490-7320 Fax: 401-808-8685 | |
Dina Silva, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 156 Mulberry St, Cranston, RI 02910 Phone: 401-428-8065 | |
Kathryn Tarpey, BACHELORS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1471 Elmwood Ave, Cranston, RI 02910 Phone: 401-490-7320 Fax: 401-490-7694 |